Unitaid joins the global health community today to mark World Hepatitis Day, an occasion for raising public awareness of the epidemic of curable liver viruses that cause 1.34 million deaths each year.
Unitaid is helping to defeat the epidemic by investing US$ 58 million in three grant projects (2015-2019) aimed at hepatitis C (HCV). The projects seek to develop new and simpler diagnostics, establish innovative models for screening and treatment in HIV/HCV co-infected populations, and devise cost-reduction strategies.
Unitaid’s investments in HCV:
Read more:
